Titan Pharma (TTNP) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. SPY
5. GOOGL
6. RMR
7. SPCX
8. DVN
9. CRGY
10. GOOG

Go back to Titan Pharma (TTNP) Tops Q2 EPS by 2c

Titan Pharmaceuticals Reports Second Quarter 2016 Financial Results

August 9, 2016 7:00 AM EDT

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/09/16 -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura" long-term, continuous drug delivery platform, today reported financial results for the second quarter ended June 30, 2016.

Titan reported $15.0 million in revenue for the second quarter of 2016, compared with approximately $0.8 million for the comparable quarter in 2015. License revenue in the second quarter of 2016 reflects the one-time milestone payment that was earned from development and commercialization... More